🔎 Trials Near Me

홈 › 유방암 › 캔자스

캔자스의 유방암 임상 시험

유방암 관련 연구 26개가 캔자스 내 여러 지역에서 참여자를 모집하고 있습니다.

캔자스의 도시

공식 연구 텍스트(영어)

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

  • HaysMed University of Kansas Health System, Hays
  • University of Kansas Cancer Center-West, Kansas City
  • University of Kansas Cancer Center, Kansas City
  • 외 5개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT03418961

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

  • University of Kansas Cancer Center, Westwood
  • Cancer Center of Kansas, Wichita
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06982521

E-Mindfulness Approaches for Living After Breast Cancer

  • Cotton O'Neil Cancer Center / Stormont Vail Health, Topeka
피험자 모집 중3상
18세 ~ 50세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06748222

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Central Care Cancer Center - Garden City, Garden City
  • Central Care Cancer Center - Great Bend, Great Bend
  • Veteran Administration Eastern Kansas Healthcare, Leavenworth
  • 외 4개
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05334069

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  • University of Kansas Medical Center (KUMC), Westwood
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05579366

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • HaysMed, Hays
  • Lawrence Memorial Hospital, Lawrence
  • The University of Kansas Cancer Center - Olathe, Olathe
  • 외 6개
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06418204

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  • Central Care Cancer Center - Garden City, Garden City
  • Central Care Cancer Center - Great Bend, Great Bend
  • HaysMed, Hays
  • 외 10개
피험자 모집 중3상
18세 ~ 60세 · 여성 · 2026. 11. 4. 업데이트됨 · NCT05879926

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

  • University of Kansas Cancer Center, Westwood
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06695845

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

  • The University of Kansas Cancer Center, Westwood
피험자 모집 중3상
60세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT06377852

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

  • University of Kansas Cancer Center, Westwood
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT06401421

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

  • University of Kansas Hospital-Cancer Center, Fairway
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT07287917

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

  • The University of Kansas Cancer Center, Westwood
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT06374459

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

  • The University of Kansas Cancer Center, Westwood
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT06757634

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

  • AMR Kansas City Oncology, Kansas City
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT06072612

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

  • Hays Medical Center Dreiling-Schmidt Cancer Institute, Hays
  • KCCC West, Kansas City
  • KCCC Overland Park, Overland Park
  • 외 3개
피험자 모집 중관찰 연구건강한 지원자 환영
전 연령 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT02302742

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

  • University of Kansas Cancer Center, Kansas City
  • University of Kansas Cancer Center-Overland Park, Overland Park
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT06500481

Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC

  • University of Kansas Medical Center, Fairway
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 12. 업데이트됨 · NCT06263543

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

  • University of Kansas Cancer Center, Kansas City
피험자 모집 중2상건강한 지원자 환영
45세 ~ 74세 · 여성 · 2026. 8. 4. 업데이트됨 · NCT06195306

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

  • University of Kansas Cancer Center, Kansas City
피험자 모집 중2상
18세 ~ 55세 · 여성 · 2026. 7. 27. 업데이트됨 · NCT06184750

HER2-positive Breast Cancer Registry

  • The University of Kansas Cancer Center, Westwood
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 7. 17. 업데이트됨 · NCT06603597

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

  • University of Kansas Cancer Center, Kansas City
피험자 모집 중2상
35세 이상 · 여성 · 2026. 7. 7. 업데이트됨 · NCT05941520

Integrated Cancer Repository for Cancer Research

  • Saint Luke's Cancer Instititute - South, Overland Park
피험자 모집 중관찰 연구건강한 지원자 환영
19세 ~ 110세 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT02012699

Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer

  • The University of Kansas Cancer Center (KUCC), Fairway
  • The University of Kansas Cancer Center - Westwood, Kansas City
  • KUCC - Indian Creek, Overland Park
  • 외 3개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 5. 6. 업데이트됨 · NCT07220135

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

  • University of Kansas Cancer Center, Kansas City
  • The University of Kansas Cancer Center - Olathe, Olathe
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • 외 8개
피험자 모집 중3상
50세 ~ 70세 · 모든 성별 · 2026. 4. 23. 업데이트됨 · NCT04852887

Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer

  • Cancer Center of Kansas, Wichita
피험자 모집 중2상
18세 이상 · 모든 성별 · 2025. 11. 10. 업데이트됨 · NCT04553770

High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer

  • University of Kansas Medical Center, Kansas City
피험자 모집 중관찰 연구건강한 지원자 환영
30세 ~ 65세 · 여성 · 2025. 10. 29. 업데이트됨 · NCT00291096

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.